ASX - Delayed Quote AUD

Elixinol Wellness Limited (EXL.AX)

0.0040 0.0000 (0.00%)
At close: April 24 at 3:44 PM GMT+10

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Mr. Ronald Dufficy BEC, FCPA Group CEO and MD 434.63k -- --
Ms. Josephine Lorenz Global CFO & Joint Company Secretary 330.18k -- --
Glen Zurcher Account Director of Investor Relations Department -- -- --
Ms. Natalie Butler Head of Marketing & Executive Director -- -- --
Ms. Sarah Prince ACIS, BA, GrdDipCorpGov, LLB Joint Company Secretary -- -- --

Elixinol Wellness Limited

680 George Street
Level 12
Sydney, NSW 2000
Australia
61 2 8280 7355 https://www.elixinolwellness.com
Sector: 
Healthcare

Description

Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

Corporate Governance

Elixinol Wellness Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Feb 28, 2024
Elixinol Wellness Limited Earnings Call

Related Tickers